Singapore markets close in 48 minutes

Innate Pharma S.A. (IPHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.4200-0.0600 (-2.42%)
At close: 04:00PM EDT
2.4200 0.00 (0.00%)
Pre-market: 04:03AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
51,901
51,901
49,580
12,110
56,155
Cost of revenue
-
-
-
-
3,042
Gross profit
-
-
-
-
53,791
Operating expenses
Research development
56,022
56,022
51,663
47,004
49,708
Selling general and administrative
11,748
11,748
14,473
15,991
12,691
Total operating expenses
64,570
64,570
66,005
59,937
55,076
Operating income or loss
-12,669
-12,669
-16,425
-47,827
1,079
Interest expense
640
640
288
312
341
Total other income/expenses net
2,562
2,562
-41,805
2,330
-2,131
Income before tax
-7,570
-7,570
-57,972
-45,478
-829
Income tax expense
0
0
0
0
0
Income from continuing operations
-7,570
-7,570
-57,972
-45,478
-829
Net income
-7,570
-7,570
-58,103
-52,809
-63,984
Net income available to common shareholders
-7,570
-7,570
-58,103
-52,809
-63,984
Basic EPS
-0.79
-0.09
-0.73
-0.66
-0.81
Diluted EPS
-0.79
-0.09
-0.73
-0.66
-0.81
Basic average shares
79,923
80,453
79,640
79,543
78,935
Diluted average shares
79,923
80,453
79,640
79,543
78,935